Bausch Health
BHC
#4658
Rank
โ‚ฌ1.78 B
Marketcap
4,80ย โ‚ฌ
Share price
-0.70%
Change (1 day)
-31.41%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): 0,84ย โ‚ฌ

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is 0,82ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -0,10ย โ‚ฌ an increase over its 2023 EPS that were of -1,37ย โ‚ฌ.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)0,84ย โ‚ฌ-925.97%
2024-0,10ย โ‚ฌ-92.59%
2023-1,37ย โ‚ฌ160.89%
2022-0,53ย โ‚ฌ-76.64%
2021-2,25ย โ‚ฌ68.45%
2020-1,34ย โ‚ฌ-68.91%
2019-4,30ย โ‚ฌ-57.11%
2018-10,04ย โ‚ฌ-272.22%
20175,83ย โ‚ฌ-199.29%
2016-5,87ย โ‚ฌ798.7%
2015-0,65ย โ‚ฌ-128.31%
20142,31ย โ‚ฌ-204.62%
2013-2,21ย โ‚ฌ602.7%
2012-0,31ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-0,20ย โ‚ฌ-124.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-0,81ย โ‚ฌ-197.94%๐Ÿ‡บ๐Ÿ‡ธ USA